Clinical Trials Browser

Phase 1 × Prostatic Neoplasms × dapagliflozin × Clear all

NCT04887935 2025-10-01

Neoadjuvant SGLT2 Inhibition in Localized Prostate Cancer

Phase 1 Recruiting

Prostatic Neoplasms